The Balance study of olezarsen (formerly AKCEA-APOCIII-LRx) administered to patients with familial chylomicronaemia syndrome (NCT04568434)
Educational partners and supporters
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.
Financial support was provided as a GMG Knowledge Gap Grant from Pfizer Inc.